Chronic learning and memory problems that plague patients with schizophrenia may have a worthy foe in a monoclonal antibody that also holds promise in the fight against cancer and is already used to treat a rare disorder …
Monoclonal antibody holds promise of reducing learning, memory …
![](https://i0.wp.com/adoseofreality.org/wp-content/uploads/2016/01/e1c7monoclonalan.jpg?resize=150%2C150&ssl=1)